Search

everythinglearnresearchcommunity

for

Search:↓

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Oral ulcers are common in SLE patients and often link to other symptoms.

Digital gangrene can be an early sign of late-onset systemic lupus erythematosus.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

COVID-19 vaccines are generally safe for people with lupus, though some may experience mild flare symptoms.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Co-trimoxazole may help treat autoimmune diseases.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.